Microbial contamination of BM products before and after processing: A report of incidence and immediate adverse events in 257 grafts

Cytotherapy

Volumn 9, Issue 5, 2007, Pages 508-513

  Vanneaux, V ^a   Fos E ^a   Robin, M ^a   Rea, D ^a   de Latour, R Peffault ^a   Biscay, N ^a   Chantre, E ^a   Robert, I ^a   Wargnier, A ^a   Traineau, R ^a   Benbunan, M ^a   Marolleau, J P ^a   Socie G ^a   Larghero, J ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Adverse events; BMT; Graft contamination; Graft processing

Indexed keywords

CEFOXITIN; CLINDAMYCIN; ERYTHROMYCIN; FOSFOMYCIN; GENTAMICIN; IMIPENEM; KANAMYCIN; OFLOXACIN; OXACILLIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PRISTINAMYCIN; RIFAMPICIN; TEICOPLANIN; TOBRAMYCIN; VANCOMYCIN;

ABDOMINAL PAIN; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ADVERSE OUTCOME; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BACTEREMIA; BACTERIUM CONTAMINATION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BRADYCARDIA; CHILD; CHRONIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; ERYTHEMA; FEMALE; HEADACHE; HODGKIN DISEASE; HUMAN; HYPERTENSION; HYPERTHERMIA; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; NAUSEA; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; SICKLE CELL ANEMIA; TACHYCARDIA; VOMITING;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS, LOCAL; BACTERIAL INFECTIONS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN; STEM CELLS; SURGICAL WOUND INFECTION; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34548561720     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240701420427     Document Type: Article

References (17)

1. Körbling, M. and Anderlini, P. (2001) Peripheral blood stem cell versus bone marrow allotransplantation: Does the source of hematopoietic stem cells matter?. Blood, 98, pp. 2900-2908.
2. Webb, IJ, Coral, FS and Andersen, JW (1996) Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering. Transfusion, 36, pp. 782-788.
3. Schwella, N., Zimmermann, R. and Heuft, HG (1994) Microbiologic contamination of peripheral blood item cell autografts. Vox Sang, 67, pp. 32-35.
4. Kamble, R., Pant, S. and Selby, GB (2005) Microbial contamination of hematopoietic progenitor cell grafts, incidence, clinical outcome, and cost-effectiveness: An analysis of 735 grafts. Transfusion, 45, pp. 874-878.
5. Mele, L., Dallavalle, FM and Verri, MG (2005) Safety control of peripheral blood progenitor cell processing: Eight year-survey of microbiological contamination and bag ruptures in a single institution. Transfus Apher Sci, 33, pp. 269-274.
6. Ritter, M., Schwedler, J. and Beyer, J. (2003) Bacterial contamination of ex vivo processed PBPC products under clean room conditions. Transfusion, 43, pp. 1587-1595.
7. Jestice, HK, Farrington, M. and Hunt, C. (1996) Bacterial contamination of peripheral blood progenitor cells for transplantation. Transfus Med, 6, pp. 103-110.
8. Prince, HM, Page, SR and Saragosa, RF (1995) Microbiologic contamination of harvested bone marrow and peripheral blood. Bone Marrow Transplant, 15, pp. 87-91.
9. Padley, D., Koontz, F. and Trigg, ME (1996) Bacterial contamination rates following processing of bone marrow and peripheral blood progenitor cell preparations. Transfusion, 36, pp. 53-56.
10. Honohan, A., Olthuis, H. and Bernards, AT (2002) Microbial contamination of cord blood stem cells. Vox Sang, 82, pp. 32-38.
11. Attarian, H., Bensinger, WI and Buckner, CD (1996) Microbial contamination of peripheral blood stem cell collections. Bone Marrow Transplant, 17, pp. 699-702.
12. Kelly, M., Roy, DC and Labbe, AC (2006) What is the clinical significance of infusing hematopoietic cell grafts contaminated with bacteria?. Bone Marrow Transplant, 38, pp. 183-188.
13. Larghero, J., Réa, D. and Esperou, H. (2006) ABO incompatible bone marrow processing for transplantation: Results of 114 procedures and analysis of immediate adverse events and hematopoietic recovery. Transfusion, 46, pp. 398-402.
14. Fang, CT, Chambers, LA and Kennedy, J. (2005) Detection of bacterial contamination in apheresis platelet products: American Red Cross experience, 2004. Transfusion, 45, pp. 1845-1852.
15. Nifong, TP, Ehmann, C. and Mierski, JA (2003) Favorable outcome after infusion of coagulase-negative staphylococci-contaminated peripheral blood hematopoietic cells for autologous transplantation. Arch Pathol Lab Med, 127, pp. 19-21.
16. Lau, SK, Woo, PC and Woo, GK (2004) Eggerthella hongkongensis sp. Nov. and Eggerthella sinensis sp. Nov., two novel Eggerthella species, account for half of the cases of Eggerthella bacteriemia. Diagn Microbiol Infect Dis, 49, pp. 255-263.
17. Brook, I. (1996) Veillonella infections in children. J Clin Microbiol, 34, pp. 1283-1285.